Drug data last refreshed 5h ago · AI intelligence enriched 4d ago
NEO-CORT-DOME is a topical cream combining hydrocortisone (a corticosteroid) and neomycin sulfate (an antibiotic) for treatment of inflammatory and infected skin conditions. It reduces inflammation and controls bacterial infection simultaneously at the site of application. The product has been in the market since 1964 and represents a classic fixed-dose combination approach to dermatological care.
As a legacy product approaching LOE with moderate competitive pressure (30/100), the brand team is likely small and focused on defensive market retention rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on NEO-CORT-DOME offers stable, defensive commercial experience in a legacy dermatology product with minimal growth trajectory; best suited for professionals seeking operational efficiency and market-maintenance skill development rather than innovation or launch experience. Career advancement on this product is limited by its LOE-approaching lifecycle status and lack of designated innovation initiatives.
Worked on NEO-CORT-DOME at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.